Xiaoyaosan formula augments adjuvant therapy and enhances postoperative breast cancer care.

3.2 QoL comparison Generally, in both the adjuvant chemotherapy plus XYS group and the adjuvant chemotherapy group, the QLQ-C30 global health status and functional scale showed a decreasing trend from T 0 to T 1 and then gradually increased thereafter to T 4 ( Figures 1A, B ); the QLQ-C30 symptom scale revealed the opposite trend ( Figure 1C ).

also in 47,180 other papers